By: IPP Bureau
Last updated : March 07, 2024 10:38 am
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Sakar Healthcare Ltd., oncology (anti-cancer) unit has received EU GMP approval with a validity of three years from audited date.
The research-driven API-integrated oncology formulation (liquid injections, Iyophilised injections, tablets, capsules, granules) manufacturing unit located at Bavla, near Ahmedabad, Gujarat has been a state-of-the-art manufacturing unit with equipment hand-picked from across the globe. The European Agency audit team inspected the manufacturing blocks of Oral Solid Dosage (Tablet, Capsule, Granules) and Injection (Liquid, Lyophilised) with packaging and storage compliances in last quarter of calendar year 2023 and has granted the approval.
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters. Meanwhile the dedicated technical team has made slow and steady advancements. 30 generic anti-cancer molecules have been developed at in-house labs and the technology transferred successfully to manufacturing units for commercial scale up.